Mutagenicity of 1,3-butadiene at the Hprt locus of T-lymphocytes following inhalation exposures of female mice and rats

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 429, Issue 1, 1999, Pages 107-125

  Meng, Quanxin ^a,b   Henderson, Rogene F ^c   Chen, Tao ^d   Heflich, Robert H ^d   Walker, Dale M ^a   Bauer, Michael J ^a,b   Reilly, Andrew A ^a,b   Walker, Vernon E ^a,b  

^a WADSWORTH CENTER   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^d NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

1,3 butadiene; Hprt; Lymphocyte; Mouse; Mutagenicity; Rat

Indexed keywords

1,3 BUTADIENE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENE MUTATION; GENOTOXICITY; INHALATION; MOUSE; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ADMINISTRATION, INHALATION; ANIMALS; BUTADIENES; CLONE CELLS; DNA MUTATIONAL ANALYSIS; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MICE; MUTAGENICITY TESTS; MUTAGENS; MUTATION; RATS; RATS, INBRED F344; SPECIES SPECIFICITY; SPLEEN; T-LYMPHOCYTES; TIME FACTORS;

ANIMALIA;

EID: 0032841055     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(99)00104-9     Document Type: Article

References (37)

1. Huff J.E., Melnick R.L., Solleveld H.A., Haseman J.K., Powers M., Miller R.A. Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure. Science. 227:1985;548-549.
2. Owen P.E., Glaiser J.R., Gaunt I.F., Pullinger D.H. Inhalation toxicity studies with 1,3-butadiene. Two-year toxicity/carcinogenicity studies in rats. Am. Ind. Hyg. Assoc. J. 48:1987;407-413.
3. Melnick R.L., Huff J., Chou B.J., Miller R. Carcinogenicity of 1,3-butadiene in C57BL/6×C3H F1 mice at low exposure concentrations. Cancer Res. 50:1990;6592-6599.
4. Melnick R.L., Huff J. 1,3-Butadiene: toxicity and carcinogenicity in laboratory animals and in humans. Rev. Environ. Contam. Toxicol. 124:1992;111-144.
5. Bond J.A., Recio L., Andjelkovich D. Epidemiological and mechanistic data suggest that 1,3-butadiene will not be carcinogenic to humans at exposures likely to be encountered in the environment or workplace. Carcinogenesis. 16:1995;165-171.
6. Melnick R.L., Kohn M.C. Mechanistic data indicate that 1,3-butadiene is a human carcinogen. Carcinogenesis. 16:1995;157-163.
7. Himmelstein M.W., Acquavella J.F., Recio L., Medinsky M.A., Bond J.A. Toxicology and epidemiology of 1,3-butadiene. Crit. Rev. Toxicol. 27:1997;1-108.
8. Meng Q., Recio L., Reilly A.A., Wong B., Bauer M., Walker V.E. Comparison of the mutagenic potency of 1,3-butadiene at the hprt locus of T-lymphocytes following inhalation exposure of female B6C3F1 mice and F344 rats. Carcinogenesis. 19:1998;1019-1027.
9. Jones I.M., Burkhart-Schultz K., Strout C.L., Crippen T.L. Cloned mouse lymphocytes permit analysis of somatic mutations that occur in vivo. Somatic Cell Mol. Genet. 13:1987;325-333.
10. Skopek T.R., Walker V.E., Cochrane J.E., Craft T.R., Cariello N.F. Mutational spectrum of N-ethyl-N-nitrosourea at the hprt locus in splenic T-cells of exposed B6C3F1 mice. Proc. Natl. Acad. Sci. U.S.A. 89:1992;7866-7870.
11. Heddle J.A. Mutant manifestation: the time factor in somatic mutagenesis. Mutagenesis. 14:1999;1-3.
12. Meng Q., Skopek T.R., Walker D.M., Hurley-Leslie S., Chen T., Zimmer D.M., Walker V.E. Culture and propagation of Hprt mutant T-lymphocytes isolated from mouse spleen. Environ. Mol. Mutagen. 32:1998;236-243.
13. Meng Q., Henderson R.F., Walker D.M., Reilly A.A., Bauer M.J., Walker V.E. Mutagenicity of the racemic mixtures of butadiene monoepoxide and butadiene diepoxide at the Hprt locus of T-lymphocytes following inhalation exposures of female mice and rats. Mutat. Res. 429:1999;127-140.
14. Walker V.E., Skopek T.R. A mouse model for the study of in vivo mutational spectra: sequence specificity of ethylene oxide at the hprt locus. Mutat. Res. 288:1993;151-162.
15. Chen T., Aidoo A., Casciano D.A., Heflich R.H. Expansion of rat 6-thioguanine-resistant T-lymphocyte clones by stimulation with ionomycin and a phorbol ester. Environ. Mol. Mutagen. 31:1998;97-102.
16. 6-alkylguanine in hprt mutagenesis in T-lymphocytes of rats exposed in vivo to ethylmethanesulfonate, N-(2-hydroxyethyl)-N-nitrosourea, or N-ethyl-N-nitrosourea. Cancer Res. 55:1995;2478-2485.
17. Cochrane J.E., Skopek T.R. Mutagenicity of butadiene and its epoxide metabolites: II. Mutational spectrum of butadiene, 1,2-epoxybutene and diepoxybutane at the hprt locus in splenic T cells from exposed B6C3F1 mice. Carcinogenesis. 15:1994;719-723.
18. Walker V.E., Gorelick N.J., Andrews J.L., Craft T.R., deBoer J.G., Glickman B.W., Skopek T.R. Frequency and spectrum of ethylnitrosourea-induced mutation at the hprt and lacI loci in splenic lymphocytes of exposed lacI transgenic mice. Cancer Res. 56:1996;4654-4661.
19. Walker V.E., Sisk S.C., Upton P.B., Wong B.A., Recio L. In vivo mutagenicity of ethylene oxide at the hprt locus in T-lymphocytes of B6C3F1 lacI transgenic mice following inhalation exposure. Mutat. Res. 392:1997;211-222.
20. A. Aidoo, L.E. Lyn-Cook, R.A. Mittelstaedt, R.H. Heflich, D.A. Casciano, Induction of 6-thioguanine-resistant lymphocytes in Fischer 344 rats following in vivo exposure to N-ethyl-N-nitrosourea and cyclophosphamide. Environ. Mol. Mutagen. 17 (1991) 141-151.
21. Aidoo A., Lyn-Cook L.E., Heflich R.H., George E.O., Casciano D.A. The effect of time after treatment, treatment schedule and animal age on the frequency of 6-thioguanine-resistant T-lymphocytes induced in Fischer 344 rats by N-ethyl-N-nitrosourea. Mutat. Res. 298:1993;169-178.
22. Tates A.D., van Dam F.J., van Teylingen C.M.M., de Zwart F.A., Zwinderman A.H. Comparison of induction of hprt mutations by 1,3-butadiene and/or its 1,2-epoxybutene and 1,2,3,4-diepoxybutane in lymphocytes from spleen of adult male mice and rats in vivo. Mutat. Res. 397:1998;21-36.
23. V.E. Walker, I.M. Jones, T.L. Crippen, Q. Meng, D.M. Walker, M.J. Bauer, A.A. Reilly, A.D. Tates, J. Nakamura, P.B. Upton, T.R. Skopek, Molecular dosimetry of N-ethyl-N-nitrosourea: relationships between DNA adduction, cell loss and proliferation, and frequency of Hprt mutant T-cells following treatment of preweanling, weanling, and adult male mice, Mutat. Res., in press.
24. Scollay R.G., Butcher E.C., Weissman I.L. Thymus cell migration: quantitative aspects of cellular traffic from the thymus to the periphery in mice. Eur. J. Immunol. 10:1980;210-218.
25. Jones I.M., Burkhart-Schultz K., Strout C.L., Crippen T.L. Factors that affect the frequency of thioguanine-resistant lymphocytes in mice following exposure to ethylnitrosourea. Environ. Mutagen. 9:1987;317-329.
26. Nicklas J.A., O'Neill J.P., Albertini R.J. Use of T-cell receptor gene probes to quantify the in vivo hprt mutations in human T-lymphocytes. Mutat. Res. 173:1986;67-72.
27. Albertini R.J., Nicklas J.A., Skopek T.R., Recio L., O'Neill J.P. Genetic instability in human T-lymphocytes. Mutat. Res. 400:1998;381-389.
28. Tates A.D., van Dam F.J., de Zwart F.A., van Teylingen C.M.M., Natarajan A.T. Development of a cloning assay with high cloning efficiency to detect induction of 6-thioguanine-resistant lymphocytes in spleen of adult mice following in vivo inhalation exposure to 1,3-butadiene. Mutat. Res. 309:1994;299-306.
29. Recio L., Sisk S., Meyer K., Pluta L., Bond J.A. Mutagenicity and mutational spectra of 1,3-butadiene in bone marrow of B6C3F1 lacI transgenic mice. Toxicology. 113:1996;106-111.
30. Recio L., Meyer K.G., Pluta L.J., Moss O.R., Saranko C.J. Assessment of 1,3-butadiene mutagenicity in bone marrow of B6C3F1 lacI transgenic mice (Big Blue®): a review of mutational spectrum and lacI mutant frequency after a 5-day 625 ppm 1,3-butadiene exposure. Environ. Mol. Mutagen. 28:1996;424-429.
31. Ma H., Wood T.G., Ward J.B. Jr. Molecular analysis of HPRT mutants from 1,3-butadiene exposed workers. Toxicologist. 48(S1):1999;126.
32. Cochrane J.E., Skopek T.R. Mutagenicity of butadiene and its epoxide metabolites: I. Mutagenic potential of 1,2-epoxybutene, 1,2,3,4-diepoxybutane and 3,4-epoxy-1,2-butanediol in cultured human lymphoblasts. Carcinogenesis. 15:1994;719-723.
33. Steen A.-M., Meyer K.G., Recio L. Analysis of hprt mutations occurring in human TK6 lymphoblastoid cells following exposure to 1,2,3,4-diepoxybutane. Mutagenesis. 12:1997;61-67.
34. Steen A.-M., Meyer K.G., Recio L. Characterization of hprt mutations following 1,2-epoxy-3-butene exposure of human TK6 cells. Mutagenesis. 12:1997;359-364.
35. Q. Meng, N. Singh, R.H. Heflich, T.R. Skopek, V.E. Walker, Comparison of the mutations at Hprt exon 3 of T-lymphocytes from B6C3F1 mice and F344 rats exposed by inhalation to 1,3-butadiene or 1,2:3,4-diepoxybutane, Mutat. Res., submitted.
36. I.-D. Adler, F. Pacchierotti (Eds.), Special issue: multi-endpoint analysis of genetic damage induced by 1,3-butadiene and its major metabolites, Mutat. Res. 397 (1) 1998.
37. Melton D.W., Konecki D.S., Brennard J., Caskey C.T. Structure, expression, and mutation of the hypoxanthine-guanine phosphoribosyltransferase gene. Proc. Natl. Acad. Sci. U.S.A. 81:1984;2147-2151.